MY ACCOUNT | NEWSLETTER |

AVMA: Association of insurance commissioners passes Pet Insurance Model Act


The American Veterinary Medical Association (AVMA) highlighted this month a recent announcement from the National Association of Insurance Commissioners that its members have passed a Pet Insurance Model Act to establish regulatory guidance for states.

The AVMA provided comments and input during the drafting process for the model state law.

In 2021, the pet health insurance industry provided insurance to about 4 million pets in the United States, up from 3.1 million pets in 2020, according to the North American Pet Health Insurance Association. The U.S. industry had premiums of about $2.5 billion in 2021, up from $2 billion in 2020, according to a story from the AVMA.

Beth Dwyer, superintendent of insurance for the Rhode Island Department of Business Regulation, said in a release that the model law establishes clear rules for the sale of pet insurance and provides important disclosures to pet owners interested in purchasing this product. “Now, it is up to the states to see if they would like to adopt or modify the model law for this regulatory framework to be in effect,” she said.

Key elements of the model include codifying consumer protections in policy renewals, required disclosures of waiting periods, policy limits, conditions and benefit schedules. The model act limits how insurers can deny pet insurance claims related to preexisting conditions of covered pets. It would also require insurers and sellers of insurance to differentiate noninsurance pet wellness programs from insurance policies.

Visit the National Association of Insurance Commissioners website to view the model act

AVMA endorses the concept of pet health insurance that provides coverage to help defray the cost of veterinary medical care and encourages veterinary teams to proactively educate their clients about the existence of such a resource. Learn more about the AVMA’s stance and weigh in on its policy on their website


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Prevalence of feline leukemia virus infection and serum antibodies against feline immunodeficiency virus in unowned free-roaming cats

Like0
Dislike0

Additive manufacturing to veterinary practice: Recovery of bony defects after the osteosarcoma resection in canines

Like0
Dislike0

Antimicrobial drug use in poultry

Like0
Dislike0

New hope and compassionate care for animal patients in pain

Like0
Dislike0

Neogen® Renews Official Sponsorship with US Equestrian to Continue Advancing Equine Health Education

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top